Presentation ESC 2021 Influenza Vaccination after Myocardial Infarction - a randomized, double-blind, placebo-controlled, multicenter trial Presenter: Ole Fröbert August 31, 2021 REGISTER for free or LOG IN to view this content Clinical Cardiology Clinical Pharma Coronary CAD Pharma Policy & Practice Guidelines Public Health Presentation ESC 2021 Myocardial Infarction Ole Fröbert Up Next Presentation ESC 2021 Cardiovascular Safety of Degarelix versus Leuprolide in Patients with Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial Presenter: Renato D. Lopes August 31, 2021 More slides + Presentation TCT 2021 Invasive versus Medical Management In Patients with Chronic Kidney Disease and Non-ST-Elevation Myocardial Infarction Presenter: Ankur Kalra October 20, 2021 Presentation TCT 2021 TCT 2021 Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award – Astonishing Group Presenter: Gregg Stone November 04, 2021 We Recommend
Presentation ESC 2021 Cardiovascular Safety of Degarelix versus Leuprolide in Patients with Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial Presenter: Renato D. Lopes August 31, 2021
Presentation TCT 2021 Invasive versus Medical Management In Patients with Chronic Kidney Disease and Non-ST-Elevation Myocardial Infarction Presenter: Ankur Kalra October 20, 2021
Presentation TCT 2021 TCT 2021 Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award – Astonishing Group Presenter: Gregg Stone November 04, 2021